A new gene that promotes NMYC activity

Alderton, Gemma K.

doi:10.1038/nrc3698

In Brief
Published: 24 February 2014

Neuroblastoma

A new gene that promotes NMYC activity

Gemma K. Alderton

Nature Reviews Cancer volume 14, page 155 (2014)Cite this article

1914 Accesses
1 Citations
Metrics details

Subjects

Metastasis

Access through your institution

Buy or subscribe

Suenaga et al. found that a cis-antisense gene of MYCN, called NCYM, encodes a protein that, like NMYC, is involved in the pathogenesis of neuroblastoma. They found that NCYM is co-amplified with MYCN in primary human neuroblastoma samples. Also, unlike Mycn transgenic mice, Mycn;Ncym transgenic mice developed metastatic neuroblastoma, which is reminiscent of human neuroblastoma with NMYC amplification. The authors showed that NCYM inhibits the activity of glycogen synthase kinase 3β (GSK3β), which targets NMYC for degradation, suggesting that NCYM promotes tumorigenesis by stabilizing NMYC.

This is a preview of subscription content, access via your institution

Access options

Access through your institution

Buy this article

Purchase on SpringerLink
Instant access to the full article PDF.

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

References

Suenaga, Y. et al. NCYM, a cis-antisense gene of MYCN, encodes a de novo evolved protein that inhibits GSK3β resulting in the stabilization of MYCN in human neuroblastomas. PLoS Genet. 10, e1003996 (2014)
Article Google Scholar

Download references

Authors